$APGE news
The latest APGE stock news: headlines, filings, AI summaries and sentiment for $APGE, updated around the clock.
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Bolster Immunology and Oncology Portfolios
- AbbVie Completes $10.9 Billion Acquisition of Apogee Therapeutics
- Apogee Therapeutics, Inc. - 8-K Filing
- Ken Griffin Increases Stake in AbbVie by 547%
- Apogee CEO Sells Shares Amid Significant Stock Price Surge
- Apogee Therapeutics CEO Sells Shares Amid Significant Stock Gain
- AbbVie's Acquisition of Apogee Therapeutics Could Strengthen Its Position as a Dividend King
- RBC Capital Maintains Sector Perform Rating on Regeneron Amid AbbVie's Acquisition of Apogee Therapeutics
- AbbVie to Acquire Apogee Therapeutics for $135.11 per Share
- AbbVie Announces $10.9 Billion Acquisition of Apogee Therapeutics
- Canaccord Raises Price Target on AbbVie Following Apogee Acquisition
- AbbVie to Acquire Apogee Therapeutics; Other Notable Press Releases
- AbbVie Announces Acquisition of Apogee Therapeutics for $10.9 Billion
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Strengthen Immunology Portfolio
- Apogee Therapeutics Shares Surge Following AbbVie's Cash Acquisition Offer
- AbbVie Announces Acquisition of Apogee Therapeutics for $10.9 Billion
- AbbVie Near Acquisition of Apogee Therapeutics in $11B Deal
- Key Stock Market Developments and Events for Monday, June 22
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Bolster Immunology Portfolio
- Apogee Therapeutics, Inc. - 8-K Filing
- Apogee Therapeutics, Inc. - 8-K Filing
- AbbVie Agrees to Acquire Apogee Therapeutics in $10.9 Billion Deal
- Apogee Therapeutics Shares Surge on Reported AbbVie Acquisition Deal
- AbbVie Near $10.9 Billion Deal to Acquire Apogee Therapeutics
- AbbVie Nearing $10.9 Billion Deal to Acquire Apogee Therapeutics
- Apogee Therapeutics, Inc. - 10-Q Filing